Skip to search formSkip to main contentSkip to account menu

HQ-275

Known as: 2,3-dihydro-2-methyl-1-(morpholinylacetyl)-3-phenyl-4(1H)-quinazolinone, monohydrochloride, HQ 275 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

MorpholinesQuinazolinones

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1974
1974
Effects of 1-morpholinoacetyl-2-methyl-3-phenyl-4-oxo-1,2,3,4-tetrahydro quinazoline hydrochloride (HQ-275) on alpha-naphtyl isothio-cyanate- and/or thioacetamide-induced liver damage in rats.
Abstract Pharmacological properties of l-morpholinoacetyl-2-methyl-3-phenyI-4-oxo-1, 2, 3, 4-tetrahydro quinazoline hydrochloride… 
1973
1973
Effects of 1-morpholinoacetyl-2-methyl-3-phenyl-4-oxo-1, 2, 3, 4-tetrahydroquinazoline hydrochloride (HQ-275) on acute experimental hepatic injury induced by carbon tetrachloride in rats.
Pharmacological effects of HQ-275 on CCl4-liver injury have been investigated, and the results compared with those of rats… 
1973
1973
Relationship of HQ-275 to biliary excretion and portal blood flow in dogs.
Abstract In a previous report we have demonstrated that l-morpholinoacetyl-2-methyl-3-phenyl-4-oxo-l, 2, 3, 4-tetrahydro… 
1972
1972
Choleretic activities of 1-morpholinoacetyl-2-methyl-3-phenyl-4-oxo-1, 2, 3, 4-tetrahydro quinazoline hydrochloride (HQ-275).
In 1959, R. Charlier reported that the most potent choleretic action was found in p-hydroxyphenyl salicylamide (Driol, PHPS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)